Susan Bullman, Ph.D.
Department of Immunology, Division of Discovery Science
Present Title & Affiliation
Primary Appointment
Associate Professor, Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor, Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Associate Member, James P. Allison Institute, MD Anderson Cancer Center
Associate Professor, Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Affiliate Investigator, Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington
Part-Time Lecturer, Department of Biological Sciences, University College Cork and Munster Technological University
Education & Training
Degree-Granting Education
| 2018 | Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston and Cancer Program, Broad Institute, Cambridge, Massachusetts, US, Postdoctoral Researcher |
| 2013 | Munster Technological University (Previously: Cork Institute of Technology), Cork, IE, PhD, Biological Sciences |
| 2009 | University College Cork, Cork, IE, BSc, Biomedical Science |
Experience & Service
Faculty Academic Appointments
Affiliate Assistant Professor, Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, 2019 - 2024
Assistant Professor, Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, 2019 - 2024
Instructor in Medicine (Faculty), Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 2018 - 2019
Administrative Appointments/Responsibilities
Director, Host-Microbial Interactions, within PRIME-TR Platform, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Faculty Advisory Committee, Data Core, Fred Hutchinson Cancer Center, Seattle, Washington, 2020 - 2025
Faculty Advisory Committee, Genomic and Bioinformatics Shared Resources, Fred Hutchinson Cancer Center, Seattle, Washington, 2020 - 2024
Faculty Advisory Committee, Experimental Histopathology Shared Resources, Fred Hutchinson Cancer Center, Seattle, Washington, 2020 - 2024
Extramural Institutional Committee Activities
Advisor, Board of Advisors, Fred Hutch Cancer Center, 2023 - Present
Committee Member, Faculty Steering Committee Center for Metastasis Research Excellence (Met-X), Fred Hutchinson Cancer Center, 2022 - 2024
Committee Member, Faculty Advisory Committee Genomics Shared Resources, Fred Hutchinson Cancer Center, 2020 - 2024
Committee Member, Faculty Advisory Committee Data Core, Fred Hutchinson Cancer Center, 2020 - 2024
Committee Member, Faculty Advisory Committee Experimental Histopathology Shared Resources, Fred Hutchinson Cancer Center, 2020 - 2024
Committee Member, Allison Institute NextGen Symposium, The University of Texas MD Anderson Cancer Center
Editorial Activities
Associate Editor, PLOS Pathogens, 2022 - 2023
External Advisory Board (EAB), The University of Texas MD Anderson Cancer Center Microbiome PRIME TR Program, 2020 - Present
Guest Editor, Anaerobe Journal Special Issue, 2020 - Present
Guest Editor, Anaerobe Journal Special Issue, 2020 - 2021
Honors & Awards
| 2025 - Present | Times100: The 100 Most Influential People of 2025, Times Magazine |
| 2025 - Present | Gianni Bonadonna Award, Fondazione Gianni Bonadonna |
| 2025 - Present | 40 Under 40 in Cancer (Rising Stars & Emerging Leaders), Association for Value-Based Cancer Care (AVBCC |
| 2021 - Present | Early Career Researcher of the Year Award, Irish Research Foundation |
| 2021 - Present | Investigator Award, UK Welcome Trust |
| 2021 | Keck Foundation Award |
| 2020 | Microbiome PRIME TR Program, The University of Texas MD Anderson Cancer Center |
| 2020 | Keynote Address ASCO GI Annual Symposium |
| 2018 | STAT 2018 Wunderkind https://www.statnews.com/wunderkinds/ |
| 2016 - Present | American Society for Microbiology Infectious Disease Travel Grant, American Society for Microbiology Infectious Disease |
| 2016 | DF/HCC Gastrointestinal SPORE Career Development Award |
| 2015 | Prevent Cancer Foundation Fellowship |
| 2014 | American Society for Microbiology Infectious Disease Travel Grant, American Society for Microbiology Infectious Disease |
| 2012 | European Congress of Clinical Microbiology and Infectious Diseases (ESCMID) Travel Grant, European Congress of Clinical Microbiology and Infectious Diseases (ESCMID) |
| 2012 | Sir. Howard Dalton Young Microbiologist of the year 2012 Finalist, Society for General Microbiology (SGM) |
| 2012 | Society for General Microbiology (SGM) graduate student Travel Grant, Society for General Microbiology (SGM) |
| 2012 | Best Postgraduate Oral Presentation, Society for General Microbiology (SGM), 2012 Spring Conference |
| 2010 | UCC Candidate for the National 'Presidents Prize', Academy of Medical Laboratory Scientists |
| 2009 | Irish Research Council for Science Engineering and Technology (IRCSET) scholarship, Irish Research Council for Science Engineering and Technology (IRCSET) |
| 2009 | University College Cork (UCC) Scholar Award, University College Cork (UCC) |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. James P. Allison Institute Annual Symposium. Invited. Houston, Texas, US.
- 2023. The Oral Microbiome – Past, Present, and Future. Invited. Cambridge, Massachusetts, US.
- 2023. The BC Cancer Research Seminar Series. Invited. Vancouver, British Columbia, CA.
- 2023. Keynote Address, PRIME TR Microbiome Symposium. Houston, Texas, US.
- 2023. James P. Alison Institute, Seminar Series. Invited. Houston, Texas, US.
- 2023. Robert Langer Seminar Series. Invited. Cambridge, Massachusetts, US.
- 2022. Wilske Seminar Series. Invited. Seattle, Washington, US.
- 2022. Impact of Intratumoral Microbiota on Spatial, Cellular and Transcriptional Heterogeneity in Human Cancer. Invited. Center for Microbiome and Human Health Seminar Series.
- 2022. Assessing the Contribution of the Intratumoral Microbiota to the Tumor Microenvironment. Invited. Cambridge, Massachusetts, US.
- 2022. WiSTEM Keynote Speaker, IE.
- 2021. The effect of the intratumoral microbiota on the tumor microenvironment. Invited.
- 2020. 7th Annual University of Cincinnati Cancer Center, Annual Faculty Retreat, Charge against Cancer. Invited. Cincinnati, Ohio, US.
- 2018. Fusobacterium-associated colorectal cancer. Invited. Cambridge, Massachusetts, US.
- 2018. Tumor Microbiota in the Progression and Treatment of Colorectal Cancer. Invited. Seattle, Washington, US.
- 2018. Role of Fusobacterium in the Progression and Treatment of Colorectal Cancer. Invited.
- 2016. Investigating the intra-tumoral microbiome of GI tract cancers. Invited. Boston, Massachusetts, US.
- 2013. Molecular Diagnostics; the changing culture of Medical Microbiology. Invited. Cork, Munster, IE.
- 2012. Emerging Dynamics of human Campylobacterosis. Invited. Dublin, Leinster, IE.
- 2011. Changing culture of medical microbiology; atypical Campylobacterosis. Invited. Ireland, IE.
- Keynote Address PRIME-TR Annual Microbiome Symposium. Invited. Houston, Texas, US.
National Presentations
- 2026. Current Research. Invited. 2025–2026 Lab wide Seminar Series. New York City, New York, US.
- 2025. Johns Hopkins Microbiome Forum Lecture. Baltimore, Maryland, US.
- 2024. Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer. Invited. AACR Special Conference, US.
- 2024. Microbiome Virtual International Forum, US.
- 2024. Annual Legorreta Cancer Center Symposium. Invited. Providence, Rhode Island, US.
- 2024. Jatin Shah Symposium: Genomic Landscape of HNSCC - Where We Are and Where We Are Going. New Directions in Microbiome Research Across Oncology. Chicago, Illinois, US.
- 2023. The 19th Annual Tucson Symposium. Invited. Tucson, Arizona, US.
- 2020. The Intratumoral Microbiota: A Role in Cancer Progression and Patient Response to Treatment. Invited. NCI Division of Cancer Biology Lecture Series.
- 2020. How the Microbiome Impacts Cancer, Immunity, and Response to Therapy. Invited. Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Cancer Symposium. San Francisco, California, US.
- 2020. The microbiome and metastatic disease. Invited. New York City, New York, US.
- 2020. The intratumoral microbiota; a component of the tumor microenvironment. Invited, US.
- 2017. The Microbiome and Response to Chemotherapy in CRC. Invited. GI SPORE Annual Meeting. Nashville, Tennessee, US.
- 2016. High-throughput sequencing based computational subtraction for microbial analysis in cancer. Invited. Cork, Munster, IE.
- Integrative Pathobiology-in-Population Sciences (IPPS). The 6th International Molecular Pathological Epidemiology (MPE) Meeting: 10-Year Anniversary Summit, US.
International Presentations
- 2025. Tumor Heterogeneity, plasticity & therapy: Progression and Metastasis. Invited. VIB Conference. Leuven, BE.
- 2025. From Microniches to Single Cells: Understanding Tumor-Infiltrating Microbes in the TME. Invited. CHUM Research Center. Montreal, CA.
- 2024. 28th Japanese Foundation for Cancer Research International Symposium. Tokyo, JP.
- 2024. Profiling Tumor Ecosystems in Native Tissue Context From Microniches to Single Cells: Understanding the impact of intratumoral microbes on spatial and cellular heterogeneity in cancer. San Diego, US.
- 2023. SITC, 38th Annual Meeting. Invited. San Diego, US.
- 2023. Primer on Tumor Immunology and Cancer Immunotherapy. Invited. San Diego, US.
- 2023. Forbeck Forum, Systemic Metabolism in Cancer. Invited. Castello, IT.
- 2023. Molecular Microbiology of Bacteria and Bacterial Infections. Invited. Wurzbach, DE.
- 2023. CRUK Marshall Symposium. Invited. West Sussex, GB.
- 2023. Understanding the Role of the Microbiome in Cancer Formation. Invited, US.
- 2022. The Tumor Microbiome. Invited. Seattle, US.
- 2021. The Intratumoral Microbiome. Invited.
- 2021. The Cancer Microbiome. Invited.
- 2020. How the Microbiome Impacts Cancer, Immunity, and Response to Therapy. Invited. San Francisco, US.
- 2020. Fusobacterium persistence and antibiotic response in colorectal cancer. Invited. Orlando, US.
- 2019. The Tumor Microbiota: A Role in Cancer Progression and Treatment. Invited. Killarney, IE.
- 2018. New Insights into Fusobacterium-Associated Colorectal Cancer. Invited. Las Vegas, US.
- 2012. Campylobacter ureolyticus; an emerging gastrointestinal pathogen?. Invited. Warwick, GB.
- 2011. Campylobacter Ureolyticus; an Emerging Gastrointestinal Pathogen. Invited. Cork, IE.
Grant & Contract Support
| Date: | 2026 - 2031 |
| Title: | Modulation of the Tumor Microenvironment by Fusobacterium Nucleatum and Co-infecting Microbes in Colorectal Cancer |
| Funding Source: | National Cancer Institute |
| Role: | PI |
| ID: | 1 R01 CA 293361 - 01 A1; Project: 00018751 |
| Date: | 2026 - 2028 |
| Title: | Engineering Microbial Cellular Therapies against Cancer |
| Funding Source: | The Mark Foundation for Cancer Research (U.S.) Ltd |
| Role: | PI |
| ID: | FP00027199; Project: 00018487 |
| Date: | 2025 - 2030 |
| Title: | Deciphering the Critical Determinants of Enteric Niche Colonization by Microbes in Colorectal Cancer |
| Funding Source: | NIH |
| Role: | Co-PI |
| ID: | 1 R01 CA288827-01A1 |
| Date: | 2024 - 2029 |
| Title: | Interrogating the Role of Bacterial Methyl-modifying Enzymes in Pathoadaptation and Host Epigenetic Interference in Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1 R01 CA290034-01 A1 |
| Date: | 2024 - 2025 |
| Title: | UTEP/UTMDA Partnership for Hispanic Cancer Disparities Research |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) (Subaward via University of Texas El Paso) |
| Role: | Mentor |
| ID: | RP 210153; Project: 00017370 |
| Date: | 2024 - 2029 |
| Title: | Targeting Intra-tumoral Microbes for the Treatment, Intervention, and Prevention of Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RR 240035 |
| Date: | 2024 - 2029 |
| Title: | Defining the landscape of bacterial-colonized microniches in tumors and their role in intratumoral heterogeneity |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1 R010 CA289812-01 |
| Date: | 2024 - 2025 |
| Title: | Assessing Microbiota-Tumor-Immune Interactions within Colorectal Cancer |
| Funding Source: | Kuni Foundation, Imagination Grant, 2024 |
| Role: | PI |
| Date: | 2023 - 2025 |
| Title: | Advanced Genetic Systems for Fusobacterium nucleatum in Oral and Extra-oral Pathologies |
| Funding Source: | NIDCR |
| Role: | Co-I |
| ID: | 1 R21 DE033533-01 |
| Date: | 2023 - 2024 |
| Title: | Identification of Fusobacterium nucleatum derived peptides as tumor associated antigens for the generation of microniche-targeting TCR T cellular therapy |
| Funding Source: | Pathogen Associated Malignancy Innovation Award |
| Role: | PI |
| Date: | 2020 - 2023 |
| Title: | A New Paradigm of Host-Microbe Epigenetic Crosstalk |
| Funding Source: | Keck Foundation |
| Role: | Co-I |
| Date: | 2020 - 2021 |
| Title: | Assessing the Interplay Between the CRC Tumor Microbiota and Cancer Therapeutics for Precision Medicine |
| Funding Source: | Pathogen Associated Malignancy Innovation Award |
| Role: | PI |
| Date: | 2020 - 2021 |
| Title: | Mapping Cellular Interactions of the Colorectal Cancer Microbiota within the Tumor Microenvironment |
| Funding Source: | Translations Data Science Integrated Research Center Pilot Project Award |
| Role: | PI |
| Date: | 2019 - 2022 |
| Title: | The Role of Fusobacterium in Colorectal Cancer Treatment, Tumor Ecology and Chemotherapeutic Efficacy |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | CA229984-01 |
| Date: | 2019 - 2020 |
| Title: | Genomic and Functional Analysis of Intra-Tumoral Microbiota in Colorectal Cancer (CRC) |
| Funding Source: | Cancer Consortium SG New Investigator Award |
| Role: | PI |
| Date: | 2018 - 2019 |
| Title: | The Role of Fusobacterium in Colorectal Cancer Treatment, Tumor Ecology and Chemotherapeutic Efficacy |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | CA229984-01 |
| Date: | 2015 - 2017 |
| Title: | Bacterial and Host Mediators in Fusobacterium-associated Colon Cancer Risk |
| Funding Source: | The Prevent Cancer Foundation; Figdor Family Trust Fellowship |
| Role: | PI |
| Date: | 2015 - 2016 |
| Title: | Identification of Host and Bacterial Mediators that Contribute to Fusobacterium-Associated Gastrointestinal Cancers |
| Funding Source: | DF/HCC Gastrointestinal SPORE CDA |
| Role: | PI |
| ID: | CA127003 |
| Date: | 2009 - 2013 |
| Title: | Graduate Research Fellowship |
| Funding Source: | Irish Research Counsel for Science, Engineering and Technology |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Gavate, RP, Zepeda Rivera, M, Jones, DS, LaCourse, KD, Bullman, S, Johnston, CD. Complete genome sequence of Peptostreptococcus anaerobius SB204, isolated from a human colonic adenocarcinoma. Microbiology Resource Announcements 14(11), 2025. e-Pub 2025. PMID: 41105497.
- Morad G, Damania AV, Melendez B, Singh BB, Veguilla FJ, Soto RA, Hoballah YM, Sahasrabhojane PV, Wong MC, Ahmed MM, Rico RN, Lewis KN, Wani K, Shamsutdinova DD, Lazcano Segura RN, Ingram DR, Goethe EA, Day A, Flores II, McDaniel LK, Chelvanambi M, Johnson SB, Dimitriou F, Gupta P, Oberai S, Zal MA, Doss P, Jamal MA, Hayase E, Wathoo C, Norberg LM, Jenkins SL, Nass S, Gumin J, Long L, Yang J, Bradley GR, Bekal MP, Dono AG, Pichardo-Rojas PS, Andrewes SW, Ballester LY, Losh JS, Liang J, Huo L, Nielsen DC, Parker Kerrigan BC, Brastianos PK, Fowlkes NW, Chang CC, Jenq RR, Gomez-Manzano C, Huse JT, Davies MA, Lazar AJ, Bhat KP, Tandon N, Esquenazi Y, Peterson CB, Puduvalli VK, Lang FF, Johnston CD, Bullman S, Ajami NJ, Ferguson SD, Wargo JA. Microbial signals in primary and metastatic brain tumors. Nat Med 31(11):3675-3688, 2025. e-Pub 2025. PMID: 41238915.
- Galeano Nino JL, Ponath F, Ajisafe VA, Becker CR, Kempchinsky AG, Zepeda-Rivera MA, Gomez JA, Wu H, Terrazas JG, Bouzek H, Cromwell E, Chanana P, Wong M, Damania A, White MG, You YN, Kopetz S, Ajami NJ, Wargo JA, Johnston CD, Bullman S. Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest. Cancer Cell, 2025. e-Pub 2025. PMID: 41106380.
- Lewis, KN, Zepeda Rivera, M, Baryiames, AA, Jones, DS, LaCourse, KD, Bullman, S, Johnston, CD. Complete genome sequence for Slackia exigua strain SB208, isolated from a human colonic adenocarcinoma. Microbiology Resource Announcements 14(10), 2025. e-Pub 2025. PMID: 40970704.
- Zepeda Rivera, M, Ponath, F, Lewis, KN, Gavate, RP, Dewhirst, FE, Tomida, J, Kawamura, Y, Tanaka, K, Bullman, S, Johnston, CD. Genome sequences of eight Fusobacterium watanabei sp. isolates. Microbiology Resource Announcements 14(8), 2025. e-Pub 2025. PMID: 40719440.
- Zepeda Rivera, M, Eisele, Y, Baryiames, AA, Wu, H, Mengoni, C, Piccinno, G, McMahon, EF, LaCourse, KD, Jones, DS, Hauner, H, Minot, SS, Segata, N, Dewhirst, FE, Johnston, CD, Bullman, S. Fusobacterium sphaericum sp. nov., isolated from a human colon tumor adheres to colonic epithelial cells and induces IL-8 secretion. Gut microbes 17(1), 2025. e-Pub 2025. PMID: 39722539.
- Choi, I, Kim, KA, Kim, SC, Park, D, Nam, KT, Cha, JH, Baek, S, Cha, J, Jo, HY, Jung, M, Zeng, MY, Matei, I, Bullman, S, Ahn, JB, Han, YD, Kim, HS, Lee, I. Secretory IgA dysfunction underlies poor prognosis in Fusobacterium-infected colorectal cancer. Gut microbes 17(1), 2025. e-Pub 2025. PMID: 40667611.
- Kim JH, Schulte AJ, Sarver AL, Lee D, Angelos MG, Frantz AM, Forster CL, O'Brien TD, Cornax I, O'Sullivan MG, Cheng N, Lewellen M, Oseth L, Kumar S, Bullman S, Pedamallu CS, Goyal SM, Meyerson M, Lund TC, Breen M, Lindblad-Toh K, Dickerson EB, Kaufman DS, Modiano JF. Hemangiosarcoma Cells Promote Conserved Host-Derived Hematopoietic Expansion. Cancer Res Commun 4(6):1467-1480, 2024. e-Pub 2024. PMID: 38757809.
- Alcolea MP, Alonso-Curbelo D, Ambrogio C, Bullman S, Correia AL, Ernst A, Halbrook CJ, Kelly GL, Lund AW, Quail DF, Ruscetti M, Shema E, Stromnes IM, Tam WL. Cancer Hallmarks: Piecing the Puzzle Together. Cancer Discov 14(4):674-682, 2024. e-Pub 2024. PMID: 38571410.
- Zepeda-Rivera M, Minot SS, Bouzek H, Wu H, Blanco-Miguez A, Manghi P, Jones DS, LaCourse KD, Wu Y, McMahon EF, Park SN, Lim YK, Kempchinsky AG, Willis AD, Cotton SL, Yost SC, Sicinska E, Kook JK, Dewhirst FE, Segata N, Bullman S, Johnston CD. A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature 628(8007):424-432, 2024. e-Pub 2024. PMID: 38509359.
- Johnston CD, Bullman S. Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance. Trends Cancer 10(2):97-99, 2024. e-Pub 2024. PMID: 38242824.
- Zepeda-Rivera MA, Eisele Y, Baryiames A, Wu H, LaCourse KD, Jones DS, Hauner H, Dewhirst FE, Minot SS, Johnston CD, Bullman S. Fusobacterium sphaericum sp. nov. , isolated from a human colon tumor, is prevalent in various human body sites and induces IL-8 secretion from colorectal cancer cells. bioRxiv, 2023. e-Pub 2023. PMID: 37398369.
- Bullman S. The intratumoral microbiota: From microniches to single cells. Cell 186(8):1532-1534, 2023. e-Pub 2023. PMID: 37059062.
- Bullman S. INVADEseq to study the intratumoural microbiota at host single-cell resolution. Nat Rev Cancer 23(4):189, 2023. e-Pub 2023. PMID: 36806839.
- Nomburg J, Bullman S, Nasrollahzadeh D, Collisson EA, Abedi-Ardekani B, Akoko LO, Atkins JR, Buckle GC, Gopal S, Hu N, Kaimila B, Khoshnia M, Malekzadeh R, Menya D, Mmbaga BT, Moody S, Mulima G, Mushi BP, Mwaiselage J, Mwanga A, Newton Y, Ng DL, Radenbaugh A, Rwakatema DS, Selekwa M, Schuz J, Taylor PR, Vaske C, Goldstein A, Stratton MR, McCormack V, Brennan P, DeCaprio JA, Meyerson M, Mmbaga EJ, Van Loon K. An international report on bacterial communities in esophageal squamous cell carcinoma. Int J Cancer 151(11):1947-1959, 2022. e-Pub 2022. PMID: 35837755.
- LaCourse KD, Zepeda-Rivera M, Kempchinsky AG, Baryiames A, Minot SS, Johnston CD, Bullman S. The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota. Cell Rep 41(7):111625, 2022. e-Pub 2022. PMID: 36384132.
- Galeano Nino JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, Futran N, Houlton J, Sather C, Sicinska E, Taylor A, Minot SS, Johnston CD, Bullman S. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature 611(7937):810-817, 2022. e-Pub 2022. PMID: 36385528.
- Salvucci M, Crawford N, Stott K, Bullman S, Longley DB, Prehn JHM. Patients with mesenchymal tumours and high Fusobacteriales prevalence have worse prognosis in colorectal cancer (CRC). Gut 71(8):1600-1612, 2022. e-Pub 2022. PMID: 34497144.
- Johnston CD, Bullman S. The tumour-associated microbiome. Nat Rev Gastroenterol Hepatol 19(6):347-348, 2022. e-Pub 2022. PMID: 35361914.
- Stepanovica M, Zepeda-Rivera MA, McGlinchey AS, Baryiames AA, Jones DS, LaCourse KD, Bullman S, Johnston CD. Complete Genome Sequence of Morganella morganii CTX51T, Isolated from a Human Cecal Adenocarcinoma. Microbiol Resour Announc 11(4):e0006622, 2022. e-Pub 2022. PMID: 35254123.
- McGlinchey AS, Zepeda-Rivera MA, Stepanovica M, Baryiames AA, Jones DS, LaCourse KD, Bullman S, Johnston CD. Complete Genome Sequence of Clostridium cadaveris IFB3C5, Isolated from a Human Colonic Adenocarcinoma. Microbiol Resour Announc 11(3):e0113521, 2022. e-Pub 2022. PMID: 35234492.
- Borozan I, Zaidi SH, Harrison TA, Phipps AI, Zheng J, Lee S, Trinh QM, Steinfelder RS, Adams J, Banbury BL, Berndt SI, Brezina S, Buchanan DD, Bullman S, Cao Y, Farris AB 3rd, Figueiredo JC, Giannakis M, Heisler LE, Hopper JL, Lin Y, Luo X, Nishihara R, Mardis ER, Papadopoulos N, Qu C, Reid EEG, Thibodeau SN, Harlid S, Um CY, Hsu L, Gsur A, Campbell PT, Gallinger S, Newcomb PA, Ogino S, Sun W, Hudson TJ, Ferretti V, Peters U. Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis. Cancer Epidemiol Biomarkers Prev 31(1):210-220, 2022. e-Pub 2022. PMID: 34737207.
- Bullman S, Eggermont A, Johnston CD, Zitvogel L. Harnessing the microbiome to restore immunotherapy response. Nat Cancer 2(12):1301-1304, 2021. e-Pub 2021. PMID: 35121929.
- Mahale P, Nomburg J, Song JY, Steinberg M, Starrett G, Boland J, Lynch CF, Chadburn A, Rubinstein PG, Hernandez BY, Weisenburger DD, Bullman S, Engels EA. Metagenomic analysis to identify novel infectious agents in systemic anaplastic large cell lymphoma. Infect Agent Cancer 16(1):65, 2021. e-Pub 2021. PMID: 34775986.
- Borowsky J, Haruki K, Lau MC, Dias Costa A, Vayrynen JP, Ugai T, Arima K, da Silva A, Felt KD, Zhao M, Gurjao C, Twombly TS, Fujiyoshi K, Vayrynen SA, Hamada T, Mima K, Bullman S, Harrison TA, Phipps AI, Peters U, Ng K, Meyerhardt JA, Song M, Giovannucci EL, Wu K, Zhang X, Freeman GJ, Huttenhower C, Garrett WS, Chan AT, Leggett BA, Whitehall VLJ, Walker N, Brown I, Bettington M, Nishihara R, Fuchs CS, Lennerz JK, Giannakis M, Nowak JA, Ogino S. Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment. Clin Cancer Res 27(10):2816-2826, 2021. e-Pub 2021. PMID: 33632927.
- Nelson ND, Meng W, Rosenfeld AM, Bullman S, Sekhar Pedamallu C, Nomburg JL, Wertheim GB, Paessler ME, Pinkus G, Hornick JL, Meyerson M, Luning Prak ET, Pillai V. Characterization of Plasmacytoid Dendritic Cells, Microbial Sequences, and Identification of a Candidate Public T-Cell Clone in Kikuchi-Fujimoto Disease. Pediatr Dev Pathol 24(3):193-205, 2021. e-Pub 2021. PMID: 33530869.
- Serna G, Ruiz-Pace F, Hernando J, Alonso L, Fasani R, Landolfi S, Comas R, Jimenez J, Elez E, Bullman S, Tabernero J, Capdevila J, Dienstmann R, Nuciforo P. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann Oncol 31(10):1366-1375, 2020. e-Pub 2020. PMID: 32569727.
- Haruki K, Kosumi K, Hamada T, Twombly TS, Vayrynen JP, Kim SA, Masugi Y, Qian ZR, Mima K, Baba Y, da Silva A, Borowsky J, Arima K, Fujiyoshi K, Lau MC, Li P, Guo C, Chen Y, Song M, Nowak JA, Nishihara R, Yanaga K, Zhang X, Wu K, Bullman S, Garrett WS, Huttenhower C, Meyerhardt JA, Giannakis M, Chan AT, Fuchs CS, Ogino S. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer. J Pathol 250(4):397-408, 2020. e-Pub 2020. PMID: 31880318.
- Nomburg J, Bullman S, Chung SS, Togami K, Walker MA, Griffin GK, Morgan EA, LeBoeuf NR, DeCaprio JA, Meyerson M, Lane AA. Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm. Blood Adv 4(6):1006-1011, 2020. e-Pub 2020. PMID: 32182365.
- Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, Ameh S, Sandel D, Liang XS, Mazzilli S, Whary MT, Meyerson M, Germain R, Blainey PC, Fox JG, Jacks T. Commensal Microbiota Promote Lung Cancer Development via gammadelta T Cells. Cell 176(5):998-1013.e16, 2019. e-Pub 2019. PMID: 30712876.
- Walker MA, Pedamallu CS, Ojesina AI, Bullman S, Sharpe T, Whelan CW, Meyerson M. GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts. Bioinformatics 34(24):4287-4289, 2018. e-Pub 2018. PMID: 29982281.
- Kosumi K, Hamada T, Koh H, Borowsky J, Bullman S, Twombly TS, Nevo D, Masugi Y, Liu L, da Silva A, Chen Y, Du C, Gu M, Li C, Li W, Liu H, Shi Y, Mima K, Song M, Nosho K, Nowak JA, Nishihara R, Baba H, Zhang X, Wu K, Wang M, Huttenhower C, Garrett WS, Meyerson ML, Lennerz JK, Giannakis M, Chan AT, Meyerhardt JA, Fuchs CS, Ogino S. The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome. Am J Pathol 188(12):2839-2852, 2018. e-Pub 2018. PMID: 30243655.
- Hamada T, Zhang X, Mima K, Bullman S, Sukawa Y, Nowak JA, Kosumi K, Masugi Y, Twombly TS, Cao Y, Song M, Liu L, da Silva A, Shi Y, Gu M, Li W, Koh H, Nosho K, Inamura K, Keum N, Wu K, Meyerhardt JA, Kostic AD, Huttenhower C, Garrett WS, Meyerson M, Giovannucci EL, Chan AT, Fuchs CS, Nishihara R, Giannakis M, Ogino S. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunol Res 6(11):1327-1336, 2018. e-Pub 2018. PMID: 30228205.
- Liu L, Tabung FK, Zhang X, Nowak JA, Qian ZR, Hamada T, Nevo D, Bullman S, Mima K, Kosumi K, da Silva A, Song M, Cao Y, Twombly TS, Shi Y, Liu H, Gu M, Koh H, Li W, Du C, Chen Y, Li C, Li W, Mehta RS, Wu K, Wang M, Kostic AD, Giannakis M, Garrett WS, Hutthenhower C, Chan AT, Fuchs CS, Nishihara R, Ogino S, Giovannucci EL. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum. Clin Gastroenterol Hepatol 16(10):1622-1631.e3, 2018. e-Pub 2018. PMID: 29702299.
- Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I. The Immune Landscape of Cancer. Immunity 48(4):812-830.e14, 2018. e-Pub 2018. PMID: 29628290.
- Bullman S, Zou T, Meyerson M. Mechanistic Insights into Transmissible Cancers of Mammals. Cancer Cell 33(4):543-544, 2018. e-Pub 2018. PMID: 29634941.
- Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, Thorsson V, Bass AJ, Laird PW. Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell 33(4):721-735.e8, 2018. e-Pub 2018. PMID: 29622466.
- Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, Gevaert O, Prunello M, Shen H, Anur P, Chen J, Cheng H, Hayes DN, Bullman S, Pedamallu CS, Ojesina AI, Sadeghi S, Mungall KL, Robertson AG, Benz C, Schultz A, Kanchi RS, Gay CM, Hegde A, Diao L, Wang J, Ma W, Sumazin P, Chiu HS, Chen TW, Gunaratne P, Donehower L, Rader JS, Zuna R, Al-Ahmadie H, Lazar AJ, Flores ER, Tsai KY, Zhou JH, Rustgi AK, Drill E, Shen R, Wong CK, Stuart JM, Laird PW, Hoadley KA, Weinstein JN, Peto M, Pickering CR, Chen Z, Van Waes C. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. Cell Rep 23(1):194-212.e6, 2018. e-Pub 2018. PMID: 29617660.
- Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Ramon Y Cajal S, Fasani R, Aguirre AJ, Ng K, Elez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358(6369):1443-1448, 2017. e-Pub 2017. PMID: 29170280.
- Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 171(3):540-556.e25, 2017. e-Pub 2017. PMID: 28988769.
- Mehta RS, Nishihara R, Cao Y, Song M, Mima K, Qian ZR, Nowak JA, Kosumi K, Hamada T, Masugi Y, Bullman S, Drew DA, Kostic AD, Fung TT, Garrett WS, Huttenhower C, Wu K, Meyerhardt JA, Zhang X, Willett WC, Giovannucci EL, Fuchs CS, Chan AT, Ogino S. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue. JAMA Oncol 3(7):921-927, 2017. e-Pub 2017. PMID: 28125762.
- Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, Kostic AD, Giannakis M, Bullman S, Milner DA, Baba H, Giovannucci EL, Garraway LA, Freeman GJ, Dranoff G, Garrett WS, Huttenhower C, Meyerson M, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 65(12):1973-1980, 2016. e-Pub 2016. PMID: 26311717.
- Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA, Masugi Y, Shi Y, Song M, da Silva A, Gu M, Li W, Hamada T, Kosumi K, Hanyuda A, Liu L, Kostic AD, Giannakis M, Bullman S, Brennan CA, Milner DA, Baba H, Garraway LA, Meyerhardt JA, Garrett WS, Huttenhower C, Meyerson M, Giovannucci EL, Fuchs CS, Nishihara R, Ogino S. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol 7(11):e200, 2016. e-Pub 2016. PMID: 27811909.
- Pedamallu CS, Bhatt AS, Bullman S, Fowler S, Freeman SS, Durand J, Jung J, Duke F, Manzo V, Cai D, Ananthakrishnan A, Ojesina AI, Ramachandran A, Gevers D, Xavier RJ, Bhan AK, Meyerson M, Yajnik V. Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn's Disease. Cell Mol Gastroenterol Hepatol 2(5):563-566.e5, 2016. e-Pub 2016. PMID: 28174737.
- Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, Kostic AD, Giannakis M, Watanabe H, Bullman S, Milner DA, Harris CC, Giovannucci E, Garraway LA, Freeman GJ, Dranoff G, Chan AT, Garrett WS, Huttenhower C, Fuchs CS, Ogino S. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol 1(5):653-61, 2015. e-Pub 2015. PMID: 26181352.
- Bullman S, Kearney K, O'Mahony M, Kelly L, Whyte P, Fanning S, Morgan JG. Identification and genetic characterization of a novel picornavirus from chickens. J Gen Virol 95(Pt 5):1094-1103, 2014. e-Pub 2014. PMID: 24496829.
- Koziel M, Lucid A, Bullman S, Corcoran GD, Lucey B, Sleator RD. Draft Genome Sequence of Campylobacter corcagiensis Strain CIT045T, a Representative of a Novel Campylobacter Species Isolated from Lion-Tailed Macaques (Macaca silenus). Genome Announc 2(2), 2014. e-Pub 2014. PMID: 24744327.
- Lucid A, Bullman S, Koziel M, Corcoran GD, Cotter PD, Sleator RD, Lucey B. Draft Genome Sequence of Campylobacter ureolyticus Strain CIT007, the First Whole-Genome Sequence of a Clinical Isolate. Genome Announc 2(2), 2014. e-Pub 2014. PMID: 24723712.
- O'Doherty A, Koziel M, De Barra L, Corcoran D, Bullman S, Lucey B, Sleator RD. Development of nalidixic acid amphotericin B vancomycin (NAV) medium for the isolation of Campylobacter ureolyticus from the stools of patients presenting with acute gastroenteritis. Br J Biomed Sci 71(1):6-12, 2014. e-Pub 2014. PMID: 24693569.
- Bullman S, Lucid A, Corcoran D, Sleator RD, Lucey B. Genomic investigation into strain heterogeneity and pathogenic potential of the emerging gastrointestinal pathogen Campylobacter ureolyticus. PLoS One 8(8):e71515, 2013. e-Pub 2013. PMID: 24023611.
- Koziel M, Lucey B, Bullman S, Corcoran GD, Sleator RD. Molecular-based detection of the gastrointestinal pathogen Campylobacter ureolyticus in unpasteurized milk samples from two cattle farms in Ireland. Gut Pathog 4(1):14, 2012. e-Pub 2012. PMID: 23151337.
- Bullman S, O'Leary J, Corcoran D, Sleator RD, Lucey B. Molecular-based detection of non-culturable and emerging campylobacteria in patients presenting with gastroenteritis. Epidemiol Infect 140(4):684-8, 2012. e-Pub 2012. PMID: 21676357.
- Bullman S, Lucey B, Sleator RD. Molecular diagnostics: the changing culture of medical microbiology. Bioeng Bugs 3(1):1-7, 2012. e-Pub 2012. PMID: 22179143.
- Bullman S, Corcoran D, O'Leary J, O'Hare D, Lucey B, Sleator RD. Emerging dynamics of human campylobacteriosis in Southern Ireland. FEMS Immunol Med Microbiol 63(2):248-53, 2011. e-Pub 2011. PMID: 22077228.
- Bullman S, Corcoran D, O'Leary J, Lucey B, Byrne D, Sleator RD. Campylobacter ureolyticus: an emerging gastrointestinal pathogen?. FEMS Immunol Med Microbiol 61(2):228-30, 2011. e-Pub 2011. PMID: 21320172.
Review Articles
- Swanton C, Bernard E, Abbosh C, Andre F, Auwerx J, Balmain A, Bar-Sagi D, Bernards R, Bullman S, DeGregori J, Elliott C, Erez A, Evan G, Febbraio MA, Hidalgo A, Jamal-Hanjani M, Joyce JA, Kaiser M, Lamia K, Locasale JW, Loi S, Malanchi I, Merad M, Musgrave K, Patel KJ, Quezada S, Wargo JA, Weeraratna A, White E, Winkler F, Wood JN, Vousden KH, Hanahan D. Embracing cancer complexity: Hallmarks of systemic disease. Cell 187(7):1589-1616, 2024. e-Pub 2024. PMID: 38552609.
- Galeano Nino JL, Wu H, LaCourse KD, Srinivasan H, Fitzgibbon M, Minot SS, Sather C, Johnston CD, Bullman S. INVADEseq to identify cell-adherent or invasive bacteria and the associated host transcriptome at single-cell-level resolution. Nat Protoc 18(11):3355-3389, 2023. e-Pub 2023. PMID: 37789194.
- Inamura K, Hamada T, Bullman S, Ugai T, Yachida S, Ogino S. Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science. Gut 71(10):2107-2122, 2022. e-Pub 2022. PMID: 35820782.
- LaCourse KD, Johnston CD, Bullman S. The relationship between gastrointestinal cancers and the microbiota. Lancet Gastroenterol Hepatol 6(6):498-509, 2021. e-Pub 2021. PMID: 33743198.
- Bullman S, Meyerson M, Kostic AD. Emerging Concepts and Technologies for the Discovery of Microorganisms Involved in Human Disease. Annu Rev Pathol 12:217-244, 2017. e-Pub 2017. PMID: 27959634.
- Bullman S. Ins and outs of suprapubic catheters--a clinician's experience. Urol Nurs 31(5):259-63; quiz 264, 2011. e-Pub 2011. PMID: 22073897.
Other Articles
- Zepeda Rivera, M, Dewhirst, FE, Bullman, S, Johnston, CD Addressing controversy in Fusobacterium nomenclature. Gut microbes 17(1), 2025. PMID: 40464118.
- Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F, Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, Liu Y, Rader J, Dhankani V, Reynolds SM, Bowlby R, Califano A, Cherniack AD, Anastassiou D, Bedognetti D, Mokrab Y, Newman AM, Rao A, Chen K, Krasnitz A, Hu H, Malta TM, Noushmehr H, Pedamallu CS, Bullman S, Ojesina AI, Lamb A, Zhou W, Shen H, Choueiri TK, Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CS, Lazar AJ, Serody JS, Demicco EG, Disis ML, Vincent BG, Shmulevich I The Immune Landscape of Cancer. Immunity 51(2):411-412, 2019. PMID: 31433971.
- Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Weinstein JN, Kwiatkowski DJ, Lerner SP Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 174(4):1033, 2018. PMID: 30096301.
Letters to the Editor
- Bullman S, Corcoran D, O'Leary J, Byrne D, Lucey B, Sleator RD. Epsilonproteobacteria in humans, New Zealand. Emerg Infect Dis 18: 1709-10; author reply 1710-1, 2012.
Patents
- Meyerson M, Bullman S. CANCER DIAGNOSTIC AND TREATMENT, 2019. Patent Number: PCT/US2018/042966.
Patient Reviews
CV information above last modified August 14, 2026
Johnston-Bullman Lab Members: The Johnston and Bullman Labs work closely together and collaborate often.
Associate Members of the Allison Institute are mid-career researchers who have made significant contributions to the field.